Clinical Profile and Pulmonary Function of Pediatric Patients with Duchenne Muscular Dystrophy at a Tertiary

Maria L Arquillo1, Elbert John V Layug2, Maria Cristina H Lozada1

  • 1Division of Pediatric Pulmonology, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.

Acta Medica Philippina
|January 6, 2025
PubMed

Insights

This study assessed the clinical profile and pulmonary function in Filipino pediatric patients with Duchenne Muscular Dystrophy (DMD). Spirometry revealed patterns of restrictive lung disease, though no significant differences were found across disease stages.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Clinical Research

Background:

  • Duchenne Muscular Dystrophy (DMD) is a progressive genetic disorder affecting muscle strength, including respiratory muscles.
  • Pulmonary complications are a major cause of morbidity and mortality in DMD patients.
  • Understanding the clinical profile and pulmonary function in pediatric DMD is crucial for management.

Purpose of the Study:

  • To determine the clinical profile and pulmonary function of pediatric patients with Duchenne Muscular Dystrophy (DMD).
  • To characterize disease progression stages in DMD.
  • To investigate the association between disease progression and spirometry variables.

Main Methods:

  • Cross-sectional study utilizing medical record review.
  • Inclusion of pediatric patients (0-18 years) with DMD.
  • Data collected from August 2018 to March 2020 at a tertiary government hospital.

Main Results:

  • 30 pediatric DMD patients were analyzed, grouped by disease stage.
  • Common comorbidities included overweight, obesity, and scoliosis in non-ambulatory patients.
  • Sleep-disordered breathing symptoms were prevalent; spirometry showed patterns of restrictive lung disease (mean FVC 66.2%, FEV1 67.7%).
  • No significant differences in pulmonary function were observed across disease progression stages.

Conclusions:

  • This is the first study on Filipino pediatric DMD patients' pulmonary function.
  • Spirometry patterns suggest restrictive lung disease.
  • Further prospective studies are needed to identify respiratory variables correlating with pulmonary function.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
245
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
47.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K